Connecting Care Teams ~ Spotlight on a Person-Centered Tumor Board for Cancer and Mental IllnessSocial Media CoordinatorSep 28, 20220 min read
CAR-Therapy Adverse Reaction Identification and Management Considerations ~ Thursday, June 12th @ Davio's
NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1
Kommentare